ENDPOINTS NEWS1d
Ver­tex signs in vi­vo gene edit­ing de­liv­ery pact for sick­le cell and tha­lassemia as it looks be­yond Cas­gevy
Vertex partners with Orna Therapeutics to develop in vivo gene editing treatments for sickle cell disease and beta ...